Welcome you inquiry, looking forward long time cooperation.
USP Orlistat for Women to Lose
Home >> >> Orlistat Powder
Orlistat Raw Powder For
Orlistat is a drug that promotes loss of weight by preventing the digestion and absorption of fat in food. In the intestine, an enzyme called lipase (produced primarily by the pancreas) breaks apart fat in food so that it can be absorbed into the body. Orlistat blocks the action of lipase and thereby prevents the breakup and absorption of fat.
Data of Orlistat Raw Powder:
Orlistat Alias: Orlipastat.
Orlistat CAS ID: 96829-58-2
Orlistat Melting point: <50 °C
Orlistat Appreance: white solid powder.
Orlistat Purity: 99% by HPLC
Orlistat is a drug that promotes loss of weight by preventing the digestion and absorption of fat in food. In the intestine, an enzyme called lipase (produced primarily by the pancreas) breaks apart fat in food so that it can be absorbed into the body.
Orlistat blocks the action of lipase and thereby prevents the breakup and absorption of fat. Orlistat blocks absorption of about 25% of the fat in a meal. The unabsorbed fat is excreted in the stool.
Combine orlistat with reduced-calorie diet
Orlistat is combined with a reduced-calorie diet to promote . Orlistat also may be used to prevent weight gain after weight has been lost. Candidates for treatment with orlistat are patients who are obese with a body mass index (a measure of obesity) of more than 30 kg/m2. Candidates also include patients with a body mass index of between 27 and 30 kg/m2 if other risk factors for arteriosclerosis are present such as high blood pressure, diabetes, and elevated blood cholesterol or triglycerides. Based on several scientific studies, the average that is achieved when orlistat is taken as recommended for six months to one year is 12.4 to 13.4 pounds.
Side effects of Orlistat:
The most common side effects of orlistat are:
oily spotting on underwear,
urgent bowel movements,
fatty or oily stools,
increased number of bowel movements,
abdominal pain or discomfort, and
inability to control stool (incontinence).
From 1 in 250 and 1 in 70 patients experienced one or more of these symptoms in the first year. Generally, the side effects occurred within three months of starting therapy. In about 50% of patients, the side effects resolved within one to four weeks, but the effects in some patients lasted six months or longer. To reduce the occurrence of these side effects, meals should contain no more than 30% fat because it is the unabsorbed fat that causes most of the symptoms. alli causes fewer side effects because it contains half the dose of prescription-strength orlistat. Patients receiving orlistat with a history of oxalate kidney stones may develop increased levels of oxalate in their urine, which may increase the risk of kidney stones. Normal form of finished products: capsules in 60 mg per or 120 mg.